KA

Kunal Arora

Active Director Director DIN 07829533
DIN 07829533 First appointment May 2017 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Kunal Arora

Data last updated:

Kunal Arora is a Director at Acots Pharmaceuticals Private Limited (since 2017). The company operates in Agriculture. Acots Pharmaceuticals Private Limited reported revenue of ₹7.5 Lakh (FY 2023).

DIN 07829533
Primary Designation Director
Industry Agriculture
First Appointment 23 May 2017
Oldest Company Age 9 yrs
Largest company Acots Pharmaceuticals Private Limited · ₹7.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20172017₹7.5 Lakh (FY 2023)Active

Board colleagues of Kunal Arora

Directorship timeline

Open interactive timeline →
Acots Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kunal Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Arora

Kunal Arora currently holds 1 directorship: Acots Pharmaceuticals Private Limited (Director, since 23 May 2017, revenue ₹7.5 Lakh (FY 2023)).

Kunal Arora was first appointed on 23 May 2017 as Director at Acots Pharmaceuticals Private Limited.

The current boards of Kunal Arora's companies include Anita Arora (Acots Pharmaceuticals Private Limited), Manoj Kumar Arora (Acots Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available